Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Condition:   Metastatic Prostate Cancer Interventions:   Drug: Enzalutamide;   Drug: Talazoparib Sponsors:   MedSIR;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials